Deteriorating or damaged cartilage is a force to be reckoned with. But ProChon Biotech’s vision is to lead in the innovation of regenerative musculoskeletal technologies.
OneMedPlace announced today that its “OneMedForum 2011” business development and finance conference for emerging healthcare and life science companies will be held January 11-13, 2011, in San Francisco at the Sir Francis Drake Hotel.
ProChon’s lead product is BioCart, a second-generation tissue regeneration implant for the treatment of joint cartilage defects and injuries.
Copyright © 2025 | WordPress Theme by MH Themes